May 2021

MIMS Full Prescribing Update

New / Revised

Product Name

Section changed

New Amgevita
New APX-Doxycycline
New APX-Sotalol
New Baxter Heparin Sodium in 0.9% Sodium Chloride
New Bimprozt
New Cabazitaxel Ever Pharma
New Carmustine Juno
New Cinacalcet Mylan
New Cipla Tenofovir + Emtricitabine 300/200
New Esomeprazole Mylan
New Esopreze
New Ferropods
New Hadlima
New Hyrimoz
New Idacio
New Kesimpta
New Levetiracetam Mylan
New Maxor EC Tabs
New Nepiten
New Noumed Amlodipine
New Noumed Ciprofloxacin
New Noumed Metoprolol
New Olmertan (New Formulation)
New Rasazil
New Sevoflurane Sandoz
New Spravato
New Trikafta
Reinstated Postella-1
Revised Acimax Adverse Effects (Undesirable Effects)
Revised Actemra Dose and Method of Administration
Revised Alkeran Adverse Effects (Undesirable Effects), Interactions with Other Medicines and Other Forms of Interactions, New contraindication, Special Warnings and Precautions for Use
Revised Alkeran Injection Adverse Effects (Undesirable Effects), Interactions with Other Medicines and Other Forms of Interactions, New contraindication, Pharmacological Properties, Special Warnings and Precautions for Use
Revised Anterone 100 Special Warnings and Precautions for Use
Revised Anterone 50 Dose and Method of Administration
Revised APO-Cyproterone Acetate 100 mg Special Warnings and Precautions for Use
Revised APO-Cyproterone Acetate 50 mg Special Warnings and Precautions for Use
Revised APO-Irbesartan Adverse Effects (Undesirable Effects)
Revised APO-Lansoprazole Special Warnings and Precautions for Use
Revised Apomine Intermittent Dose and Method of Administration
Revised APX-Quetiapine XR Adverse Effects (Undesirable Effects), Overdose
Revised Asacol New Presentation of Brand already available, Pharmaceutical Form
Revised Aubagio Special Warnings and Precautions for Use
Revised Azapin Effects on Ability to Drive and Use Machines, Interactions with Other Medicines and Other Forms of Interactions, Pharmacological Properties, Physicochemical Properties, Special Warnings and Precautions for Use
Revised Azithromycin-AFT Fertility, Pregnancy and Lactation, Incompatibilities, Interactions with Other Medicines and Other Forms of Interactions, Shelf Life
Revised Baxter Cardioplegia Solution A List of Excipients, Physicochemical Properties, Product Name change
Revised Benadryl Original Oral Liquid Adverse Effects (Undesirable Effects), Fertility, Pregnancy and Lactation, Overdose, Special Warnings and Precautions for Use
Revised Bisolvon Chesty Forte Oral Liquid Contraindications, Special Warnings and Precautions for Use
Revised Bisolvon Chesty Forte Tablets Contraindications, Special Warnings and Precautions for Use
Revised Bisolvon Chesty Oral Liquid Contraindications, Special Warnings and Precautions for Use
Revised Bisolvon Dry Interactions with Other Medicines and Other Forms of Interactions, Overdose, Special Warnings and Precautions for Use
Revised Bisoprolol Sandoz List of Excipients, Qualitative and Quantitative Composition
Revised Blooms the Chemist Irbesartan Adverse Effects (Undesirable Effects)
Revised Brilinta Adverse Effects (Undesirable Effects), Special Warnings and Precautions for Use
Revised Brimica Genuair 340/12 Adverse Effects (Undesirable Effects), Pharmacological Properties, Special Warnings and Precautions for Use
Revised Brufen Plus 200/12.8 Interactions with Other Medicines and Other Forms of Interactions, Overdose, Special Warnings and Precautions for Use
Revised Burinex Nature and Contents of Container, Pharmaceutical Form
Revised Celecoxib GH Special Warnings and Precautions for Use
Revised Cipla Pain Relief Paracetamol and Codeine 8 Boxed Warnings, Contraindications, Effects on Ability to Drive and Use Machines, Interactions with Other Medicines and Other Forms of Interactions, Special Warnings and Precautions for Use
Revised Coversyl Adverse Effects (Undesirable Effects), Contraindications, Interactions with Other Medicines and Other Forms of Interactions, Physicochemical Properties, Special Warnings and Precautions for Use
Revised Coversyl Plus Adverse Effects (Undesirable Effects), Contraindications, Interactions with Other Medicines and Other Forms of Interactions, Special Warnings and Precautions for Use
Revised COVID-19 Vaccine AstraZeneca Adverse Effects (Undesirable Effects), Dose and Method of Administration, Special Warnings and Precautions for Use
Revised Cyramza Adverse Effects (Undesirable Effects), Special Warnings and Precautions for Use
Revised DBL Dexamethasone Sodium Phosphate Injection Adverse Effects (Undesirable Effects), Effects on Ability to Drive and Use Machines, Nature and Contents of Container, Special Warnings and Precautions for Use
Revised DBL Dexamethasone Sodium Phosphate Injection Ampoule Adverse Effects (Undesirable Effects), Effects on Ability to Drive and Use Machines, Nature and Contents of Container, Special Warnings and Precautions for Use
Revised DBL Morphine Sulfate Injection BP Adverse Effects (Undesirable Effects), Dose and Method of Administration, Incompatibilities, Interactions with Other Medicines and Other Forms of Interactions, New contraindication, Overdose, Special Warnings and Precautions for Use
Revised DBL Octreotide Injection Adverse Effects (Undesirable Effects), Dose and Method of Administration, Effects on Ability to Drive and Use Machines, Fertility, Pregnancy and Lactation, Interactions with Other Medicines and Other Forms of Interactions, Nature and Contents of Container, Pharmacological Properties, Special Precautions for Storage, Special Warnings and Precautions for Use
Revised Definity Sponsor
Revised Dermatane Sponsor
Revised Enalapril Sandoz Interactions with Other Medicines and Other Forms of Interactions, Special Warnings and Precautions for Use
Revised Enbrel Dose and Method of Administration, Nature and Contents of Container, Qualitative and Quantitative Composition, Special Precautions for Storage, Special Warnings and Precautions for Use
Revised Esomeprazole Sandoz Hp7 Physicochemical Properties, Qualitative and Quantitative Composition
Revised Faslodex New indication, Pharmacological Properties
Revised Fluarix Tetra Qualitative and Quantitative Composition
Revised Fluzole Interactions with Other Medicines and Other Forms of Interactions
Revised Gynotril Adverse Effects (Undesirable Effects), Sponsor
Revised Idaprex Adverse Effects (Undesirable Effects), Contraindications, Interactions with Other Medicines and Other Forms of Interactions, Physicochemical Properties, Special Warnings and Precautions for Use
Revised Idaprex Combi 4/1.25 Adverse Effects (Undesirable Effects), Contraindications, Interactions with Other Medicines and Other Forms of Interactions, Special Warnings and Precautions for Use
Revised Ikotab Adverse Effects (Undesirable Effects), Interactions with Other Medicines and Other Forms of Interactions, Pharmacological Properties, Special Warnings and Precautions for Use
Revised Imbruvica Adverse Effects (Undesirable Effects), Special Warnings and Precautions for Use
Revised Imovane Nature and Contents of Container
Revised Imukin TGA Date
Revised Indosyl Combi 4/1.25 Adverse Effects (Undesirable Effects), Contraindications, Interactions with Other Medicines and Other Forms of Interactions, Physicochemical Properties, Special Warnings and Precautions for Use
Revised Indosyl Mono Adverse Effects (Undesirable Effects), Contraindications, Interactions with Other Medicines and Other Forms of Interactions, Physicochemical Properties, Special Warnings and Precautions for Use
Revised Intuniv Adverse Effects (Undesirable Effects), Special Warnings and Precautions for Use
Revised John Plunkett's Psor-Asist Cream Product Name change
Revised Kombiglyze XR Dose and Method of Administration
Revised Kyleena Special Warnings and Precautions for Use
Revised Kyprolis Adverse Effects (Undesirable Effects)
Revised Lantheus Thallium (201TI) Chloride Injection Product Name change, Special Warnings and Precautions for Use, Sponsor
Revised Levemir Nature and Contents of Container, TGA Date
Revised Losec Tablets Adverse Effects (Undesirable Effects)
Revised Lucrin Depot Paediatric Prefilled Dual Chamber Syringe (PDS) Injection 3 Month Adverse Effects (Undesirable Effects), Contraindications, Dose and Method of Administration, Fertility, Pregnancy and Lactation, List of Excipients, Nature and Contents of Container, Overdose, Pharmacological Properties, Physicochemical Properties, Qualitative and Quantitative Composition, Special Warnings and Precautions for Use, Therapeutic Indications
Revised Lucrin Depot Prefilled Dual Chamber Syringe (PDS) Injection Adverse Effects (Undesirable Effects), Contraindications, Dose and Method of Administration, Fertility, Pregnancy and Lactation, List of Excipients, Nature and Contents of Container, Overdose, Pharmacological Properties, Physicochemical Properties, Qualitative and Quantitative Composition, Special Warnings and Precautions for Use, Therapeutic Indications
Revised Lynparza Tablets Adverse Effects (Undesirable Effects), Dose and Method of Administration, Interactions with Other Medicines and Other Forms of Interactions, Pharmacological Properties, Special Warnings and Precautions for Use, Therapeutic Indications
Revised Lypralin Boxed Warnings, Interactions with Other Medicines and Other Forms of Interactions, Overdose, Special Warnings and Precautions for Use
Revised Maxydol Boxed Warnings, Contraindications, Interactions with Other Medicines and Other Forms of Interactions, Special Warnings and Precautions for Use
Revised Mayzent Adverse Effects (Undesirable Effects), Dose and Method of Administration, Interactions with Other Medicines and Other Forms of Interactions, New contraindication, Special Warnings and Precautions for Use
Revised Meloxibell Adverse Effects (Undesirable Effects), Dose and Method of Administration, Pharmacological Properties, Special Warnings and Precautions for Use
Revised Mesasal Adverse Effects (Undesirable Effects), Interactions with Other Medicines and Other Forms of Interactions, Special Warnings and Precautions for Use
Revised Mestinon Qualitative and Quantitative Composition
Revised Mirena Special Warnings and Precautions for Use
Revised Neurolite Sponsor
Revised Norditropin Deleted Presentation
Revised Ocrevus Dose and Method of Administration
Revised Odaplix SR Adverse Effects (Undesirable Effects), Interactions with Other Medicines and Other Forms of Interactions, Physicochemical Properties, Qualitative and Quantitative Composition, Special Warnings and Precautions for Use
Revised Omepral Tablets Adverse Effects (Undesirable Effects)
Revised Ovestin Tablets Interactions with Other Medicines and Other Forms of Interactions
Revised Pacrolim Qualitative and Quantitative Composition
Revised Perindo Adverse Effects (Undesirable Effects), Contraindications, Interactions with Other Medicines and Other Forms of Interactions, Special Warnings and Precautions for Use
Revised Perindo Combi 4/1.25 Adverse Effects (Undesirable Effects), Contraindications, Interactions with Other Medicines and Other Forms of Interactions, Special Warnings and Precautions for Use
Revised Perindopril and Indapamide AN 4/1.25 Adverse Effects (Undesirable Effects), Contraindications, Interactions with Other Medicines and Other Forms of Interactions, Physicochemical Properties, Special Warnings and Precautions for Use
Revised Pfizer (Australia) Vincristine Sulfate Dose and Method of Administration, Product Name change
Revised Pharmacor Cyproterone 100 Special Warnings and Precautions for Use
Revised Pharmacor Cyproterone 50 Dose and Method of Administration
Revised Pradaxa Adverse Effects (Undesirable Effects), Dose and Method of Administration, Overdose, Special Warnings and Precautions for Use
Revised Precedex Adverse Effects (Undesirable Effects), Effects on Ability to Drive and Use Machines, Interactions with Other Medicines and Other Forms of Interactions, Pharmacological Properties, Physicochemical Properties
Revised Precedex Ready to Use Effects on Ability to Drive and Use Machines, Interactions with Other Medicines and Other Forms of Interactions
Revised Prexum Adverse Effects (Undesirable Effects), Contraindications, Interactions with Other Medicines and Other Forms of Interactions, Nature and Contents of Container, Physicochemical Properties, Special Warnings and Precautions for Use
Revised Prexum Combi Adverse Effects (Undesirable Effects), Contraindications, Interactions with Other Medicines and Other Forms of Interactions, Physicochemical Properties, Special Warnings and Precautions for Use
Revised Quetia XR Adverse Effects (Undesirable Effects), Overdose
Revised Reaptan Adverse Effects (Undesirable Effects), Contraindications, Interactions with Other Medicines and Other Forms of Interactions, Physicochemical Properties, Special Warnings and Precautions for Use
Revised Remicade Adverse Effects (Undesirable Effects)
Revised Revlimid Adverse Effects (Undesirable Effects), Special Warnings and Precautions for Use
Revised Revolade Adverse Effects (Undesirable Effects), Dose and Method of Administration, Pharmacological Properties, Special Warnings and Precautions for Use
Revised Rhinocort Hayfever & Allergy Original Adverse Effects (Undesirable Effects), Effects on Ability to Drive and Use Machines, Fertility, Pregnancy and Lactation, Interactions with Other Medicines and Other Forms of Interactions, Overdose, Special Warnings and Precautions for Use
Revised Salbutamol Cipla Fertility, Pregnancy and Lactation, Overdose, Pharmaceutical Form
Revised Samsca Qualitative and Quantitative Composition
Revised Seasonique Adverse Effects (Undesirable Effects), Interactions with Other Medicines and Other Forms of Interactions, List of Excipients, Nature and Contents of Container, New contraindication, Special Warnings and Precautions for Use
Revised Septrin Forte TGA Date
Revised Septrin Sugar Free Oral Liquid Interactions with Other Medicines and Other Forms of Interactions, Physicochemical Properties, Special Warnings and Precautions for Use
Revised Sinemet CR 200/50 Dose and Method of Administration, List of Excipients, Nature and Contents of Container, Pharmaceutical Form, Product Name change
Revised Solicare Sponsor
Revised Solu-Medrol Dose and Method of Administration
Revised Somac Heartburn Relief Adverse Effects (Undesirable Effects)
Revised Sylvant TGA Date
Revised Tafinlar Adverse Effects (Undesirable Effects), Dose and Method of Administration, Fertility, Pregnancy and Lactation, Pharmacological Properties, Special Warnings and Precautions for Use
Revised TechneLite TGA Date
Revised Telmisartan HCT GH Adverse Effects (Undesirable Effects), Contraindications, Dose and Method of Administration, Effects on Ability to Drive and Use Machines, Interactions with Other Medicines and Other Forms of Interactions, Pharmaceutical Form, Pharmacological Properties, Special Warnings and Precautions for Use
Revised Teltartan HCT Adverse Effects (Undesirable Effects), Dose and Method of Administration, Effects on Ability to Drive and Use Machines, Interactions with Other Medicines and Other Forms of Interactions, New contraindication, Pharmacological Properties, Special Warnings and Precautions for Use
Revised Tenaxil SR Adverse Effects (Undesirable Effects), Interactions with Other Medicines and Other Forms of Interactions, Special Warnings and Precautions for Use
Revised Teriflagio Adverse Effects (Undesirable Effects), Fertility, Pregnancy and Lactation, New contraindication, Special Warnings and Precautions for Use
Revised Trust Ibuprofen Plus Codeine Adverse Effects (Undesirable Effects), Dose and Method of Administration, Interactions with Other Medicines and Other Forms of Interactions, Special Warnings and Precautions for Use
Revised Ursodox GH Fertility, Pregnancy and Lactation, Interactions with Other Medicines and Other Forms of Interactions, List of Excipients, Nature and Contents of Container, Pharmaceutical Form, Pharmacological Properties, Special Precautions for Storage, Special Warnings and Precautions for Use
Revised Vaxigrip Tetra Adverse Effects (Undesirable Effects), Dose and Method of Administration, Fertility, Pregnancy and Lactation, Nature and Contents of Container, New indication, Pharmacological Properties, Special Warnings and Precautions for Use
Revised Vemlidy Adverse Effects (Undesirable Effects), Dose and Method of Administration, Pharmacological Properties, Special Warnings and Precautions for Use
Revised Vimpat Adverse Effects (Undesirable Effects), Dose and Method of Administration, New indication, Pharmacological Properties
Revised Vimpat Injection Adverse Effects (Undesirable Effects), Dose and Method of Administration, New indication, Pharmacological Properties
Revised ViruPOS TGA Date
Revised Vzole Adverse Effects (Undesirable Effects), Contraindications, Interactions with Other Medicines and Other Forms of Interactions
Revised Xolair Adverse Effects (Undesirable Effects), Dose and Method of Administration, Fertility, Pregnancy and Lactation, Interactions with Other Medicines and Other Forms of Interactions, New indication, Pharmacological Properties, Special Warnings and Precautions for Use
Revised Xtandi Adverse Effects (Undesirable Effects), Contraindications, Dose and Method of Administration, Fertility, Pregnancy and Lactation, Interactions with Other Medicines and Other Forms of Interactions, Pharmacological Properties, Special Warnings and Precautions for Use, Therapeutic Indications
Revised Zoely Sponsor
Revised Zomig Pharmacological Properties
Revised Zopral Pharmacological Properties, Pharmacological Properties
Revised Zopral ODT Pharmacological Properties, Pharmacological Properties
Revised Zyban SR Interactions with Other Medicines and Other Forms of Interactions, Special Warnings and Precautions for Use
Deleted Aquinafil
Deleted Bisolvon Chesty Forte Soluble Tablets
Deleted Caprilon
Deleted Enalapril AN
Deleted Generaid Plus
Deleted GenRx Famotidine
Deleted Hepatamine
Deleted Letrozole Generichealth
Deleted MSUD Maxamaid
Deleted Phlexy-10 Drink Mix
Deleted Redoxon Double Action
Deleted Trihexyphenidyl Hydrochloride Tablets USP 2 mg
Deleted XP Maxamaid

This list is a summary of only some of the changes that have occurred over the last month. Before prescribing, always refer to the full product information.

Copyright © MIMS Australia Pty Ltd. All rights reserved.

MIMS Australia
Suite 302, Level 3, 53 Berry Street
North Sydney NSW 2060
Phone: 1800 800 629
info@mims.com.au
www.mims.com.au